Cidara Therapeutics, Inc. short interest in 2024
In 2024, Cidara Therapeutics, Inc.'s disclosed short interest ran from 0.69% of shares outstanding on 12 Jan 2024 to 1.09% on 31 Dec 2024, a change of +0.40 percentage points. The year's high was 1.41% on 15 Aug 2024 and its low 0.18% on 15 Apr 2024, averaging 0.72% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.43 days on 15 Aug 2024. Full history: Cidara Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2024 in figures
- Start of year
- 0.69% (12 Jan 2024)
- End of year
- 1.09% (31 Dec 2024)
- Change
- +0.40 pp
- High
- 1.41% (15 Aug 2024)
- Low
- 0.18% (15 Apr 2024)
- Average
- 0.72%
- Highest days to cover
- 5.43 (15 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 0.69% | 1.43 | |
| 31 Jan 2024 | 0.66% | 1.00 | |
| 15 Feb 2024 | 0.51% | 1.06 | |
| 29 Feb 2024 | 0.24% | 1.00 | |
| 15 Mar 2024 | 0.20% | 1.00 | |
| 28 Mar 2024 | 0.22% | 1.00 | |
| 15 Apr 2024 | 0.18% | 1.00 | |
| 15 Aug 2024 | 1.41% | 5.43 | 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 30 Aug 2024 | 1.08% | 3.21 | |
| 13 Sep 2024 | 0.93% | 3.89 | |
| 30 Sep 2024 | 1.19% | 4.31 | |
| 15 Oct 2024 | 0.95% | 4.55 | |
| 31 Oct 2024 | 0.92% | 2.77 | |
| 15 Nov 2024 | 0.71% | 2.40 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 0.75% | 1.00 | |
| 13 Dec 2024 | 0.51% | 1.00 | |
| 31 Dec 2024 | 1.09% | 1.00 |
See also: Cidara Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.